United States
Print page content Print
Increase text size Decrease text size
Text Size
Cytopoint logo
Roscoe Before and Roscoe After

CYTOPOINT™ is effective and safe in dogs younger than
12 months1

ROSCOE, male, age 7 months, American Staffordshire Terrier

Veterinarian: Dr Mary Schick, Atlanta Veterinary Specialists®, Atlanta, GA

Roscoe, at just 7 months, already had a history of atopic dermatitis

Presentation and history

Roscoe arrived wearing socks and not one, but two Elizabethan collars. Despite this protection, he was completely preoccupied with the need to scratch himself. Even though his hind paws were covered with socks, they were red and inflamed. Many treatments had failed, including multiple antimicrobials, ivermectin, lime dips and a diet trial. The owners reported that Roscoe’s itch problem was having a negative effect on the whole family.

Roscoe

Roscoe’s CYTOPOINT treatments gave him long-lasting relief

Treatment decision

Dr Schick administered CYTOPOINT, and gave Roscoe a second treatment 34 days after the first injection.

Treatment result

Roscoe’s second treatment with CYTOPOINT lasted nearly 10 weeks. About 5 weeks after the injection, Roscoe presented for a bath, but he did not need another injection at that point. At 72 days, he was just beginning to chew his feet again. He no longer required any prescription drugs, E-collars or socks.

Roscoe Video 2

“[Roscoe’s owner] is very excited. Roscoe’s response to treatment with CYTOPOINT… had such a profound effect on their family’s life!”

— Dr Mary Schick, 5/18/16

Atlanta Veterinary Specialists® is a trademark of AVS GROUP, INC. and used under license by Atlanta Veterinary Specialists.

The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only, and the experiences and opinions in this video may be unique to the patient and the speaker. Individual results may vary considering the unique characteristics of the patient.

Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.

Reference: 1. Data on file, CYTOPOINT Case Studies, Zoetis Inc.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
Zoetis Services LLC. All rights reserved. CYT-00243